Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of LENZ Therapeutics Inc (NASDAQ: LENZ) closed at $25.89 in the last session, down -11.03% from day before closing price of $29.10. In other words, the price has decreased by -$11.03 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
We take a closer look at LENZ’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 20.36 and its Current Ratio is at 20.36. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 18, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $60.
On September 27, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $37.Raymond James initiated its Outperform rating on September 27, 2024, with a $37 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’24 when Chevallard Daniel R. bought 3,188 shares for $15.68 per share. The transaction valued at 49,988 led to the insider holds 3,188 shares of the business.
MCCOLLUM JAMES W bought 31,332 shares of LENZ for $501,093 on May 13 ’24. The Director now owns 525,565 shares after completing the transaction at $15.99 per share.
Stock Price History:
Over the past 52 weeks, LENZ has reached a high of $38.93, while it has fallen to a 52-week low of $14.42. The 50-Day Moving Average of the stock is 6.30%, while the 200-Day Moving Average is calculated to be -0.61%.
Shares Statistics:
A total of 27.52M shares are outstanding, with a floating share count of 22.61M. Insiders hold about 17.90% of the company’s shares, while institutions hold 79.27% stake in the company.
